B cells in autoimmune and neurodegenerative central nervous system diseases
The DOI matches its Crossref record; 334 of the 334 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–334 of 334
Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis
Spadaro, M., Gerdes, L. A., Krumbholz, M., Ertl-Wagner, B., Thaler, F. S., Schuh, E., Metz, I., Blaschek, A., Dick, A., Brück, W., et al. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000257 · Cited by 206
Kaneko, K., Sato, D. K., Nakashima, I., Ogawa, R., Akaishi, T., Takai, Y., Nishiyama, S., Takahashi, T., Misu, T., Kuroda, H., et al. (2018) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-317969 · Cited by 203
Weksler, M. E., Relkin, N., Turkenich, R., LaRusse, S., Zhou, L., & Szabo, P. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00029-3 · Cited by 201
Xiao, B.-G., Linington, C., & Link, H. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90014-x · Cited by 197
Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein
Spadaro, M., Winklmeier, S., Beltrán, E., Macrini, C., Höftberger, R., Schuh, E., Thaler, F. S., Gerdes, L. A., Laurent, S., Gerhards, R., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25291 · Cited by 196
Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins
Brändle, S. M., Obermeier, B., Senel, M., Bruder, J., Mentele, R., Khademi, M., Olsson, T., Tumani, H., Kristoferitsch, W., Lottspeich, F., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522730113 · Cited by 190
Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?
Kim, S.-H., Kim, W., Li, X. F., Jung, I.-J., & Kim, H. J. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512439439 · Cited by 189
Reduced T helper and B lymphocytes in Parkinson's disease
Stevens, C. H., Rowe, D., Morel-Kopp, M.-C., Orr, C., Russell, T., Ranola, M., Ward, C., & Halliday, G. M. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.07.015 · Cited by 189
IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum
Shimizu, J., Hatanaka, Y., Hasegawa, M., Iwata, A., Sugimoto, I., Date, H., Goto, J., Shimizu, T., Takatsu, M., Sakurai, Y., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f8832e · Cited by 188
Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid
Owens, G. P., Bennett, J. L., Lassmann, H., O'Connor, K. C., Ritchie, A. M., Shearer, A., Lam, C., Yu, X., Birlea, M., DuPree, C., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21641 · Cited by 188
Hjelmström, P., Juedes, A. E., Fjell, J., & Ruddle, N. H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4480 · Cited by 186
Autoantibodies to alpha‐synuclein in inherited Parkinson’s disease
Papachroni, K. K., Ninkina, N., Papapanagiotou, A., Hadjigeorgiou, G. M., Xiromerisiou, G., Papadimitriou, A., Kalofoutis, A., & Buchman, V. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04365.x · Cited by 185
Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro
Lisak, R. P., Benjamins, J. A., Nedelkoska, L., Barger, J. L., Ragheb, S., Fan, B., Ouamara, N., Johnson, T. A., Rajasekharan, S., & Bar-Or, A. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.02.015 · Cited by 180
Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort
Ketelslegers, I. A., Van Pelt, D. E., Bryde, S., Neuteboom, R. F., Catsman-Berrevoets, C. E., Hamann, D., & Hintzen, R. Q. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514566666 · Cited by 179
Histopathology and clinical course of MOG-antibody-associated encephalomyelitis
Spadaro, M., Gerdes, L. A., Mayer, M. C., Ertl-Wagner, B., Laurent, S., Krumbholz, M., Breithaupt, C., Högen, T., Straube, A., Giese, A., et al. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.164 · Cited by 176
Lalive, P. H., Menge, T., Delarasse, C., Della Gaspera, B., Pham-Dinh, D., Villoslada, P., von Büdingen, H.-C., & Genain, C. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510672103 · Cited by 173
Restricted use of VH4 Germline segments in an acute multiple sclerosis brain
Owens, G. P., Kannus, H., Burgoon, M. P., Smith‐Jensen, T., Devlin, M. E., & Gilden, D. H. (1998) · Annals of Neurology · doi:10.1002/ana.410430214 · Cited by 173
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype
Pröbstel, A.-K., Rudolf, G., Dornmair, K., Collongues, N., Chanson, J.-B., Sanderson, N. S., Lindberg, R. L., Kappos, L., de Seze, J., & Derfuss, T. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0256-1 · Cited by 169
Self-citationAntibodies from Inflamed Central Nervous System Tissue Recognize Myelin Oligodendrocyte Glycoprotein
O’Connor, K. C., Appel, H., Bregoli, L., Call, M. E., Catz, I., Chan, J. A., Moore, N. H., Warren, K. G., Wong, S. J., Hafler, D. A., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1974 · Cited by 168
Ephrin‐B2 prevents N‐methyl‐D‐aspartate receptor antibody effects on memory and neuroplasticity
Planagumà, J., Haselmann, H., Mannara, F., Petit‐Pedrol, M., Grünewald, B., Aguilar, E., Röpke, L., Martín‐García, E., Titulaer, M. J., Jercog, P., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24721 · Cited by 168
Tao, C., Simpson, S., Taylor, B. V., Blizzard, L., Lucas, R. M., Ponsonby, A.-L., Broadley, S., AusLong/Ausimmune Investigators Group, & van der Mei, I. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00418 · Cited by 167
Menal, M. J., Jorba, I., Torres, M., Montserrat, J. M., Gozal, D., Colell, A., Piñol-Ripoll, G., Navajas, D., Almendros, I., & Farré, R. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00001 · Cited by 165
Peschl, P., Schanda, K., Zeka, B., Given, K., Böhm, D., Ruprecht, K., Saiz, A., Lutterotti, A., Rostásy, K., Höftberger, R., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0984-5 · Cited by 163
Defining distinct features of anti-MOG antibody associated central nervous system demyelination
Weber, M. S., Derfuss, T., Metz, I., & Brück, W. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418762083 · Cited by 161
A phase 3 trial of IV immunoglobulin for Alzheimer disease
Relkin, N. R., Thomas, R. G., Rissman, R. A., Brewer, J. B., Rafii, M. S., van Dyck, C. H., Jack, C. R., Sano, M., Knopman, D. S., Raman, R., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003904 · Cited by 157
Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor
Hara, M., Martínez‐Hernández, E., Ariño, H., Armangué, T., Spatola, M., Petit‐Pedrol, M., Saiz, A., Rosenfeld, M. R., Graus, F., & Dalmau, J. O. (2018) · Neurology · doi:10.1212/wnl.0000000000005329 · Cited by 157
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Swami, M. (2011) · Nature Medicine · doi:10.1038/nm.2482 · Cited by 156
Gut microbiome analysis in neuromyelitis optica reveals overabundance of Clostridium perfringens
Cree, B. A. C., Spencer, C. M., Varrin‐Doyer, M., Baranzini, S. E., & Zamvil, S. S. (2016) · Annals of Neurology · doi:10.1002/ana.24718 · Cited by 155
Self-citationLebar, R., Lubetzki, C., Vincent, C., Lombrail, P., & Boutry, J. M. (1986) · PubMed Central · Cited by 151
Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
Komori, M., Lin, Y. C., Cortese, I., Blake, A., Ohayon, J., Cherup, J., Maric, D., Kosa, P., Wu, T., & Bielekova, B. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.293 · Cited by 151
Clinical utility of testing AQP4-IgG in CSF
Majed, M., Fryer, J. P., McKeon, A. B., Lennon, V. A., & Pittock, S. J. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000231 · Cited by 149
Jarius, S., Eichhorn, P., Franciotta, D. M., Petereit, H.-F., Akman‐Demir, G., Wick, M. W., & Wildemann, B. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8360-4 · Cited by 147
Zamvil, S. S., Nelson, P. A., Mitchell, D. J., Knobler, R. L., Fritz, R. B., & Steinman, L. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.6.2107 · Cited by 143
Self-citationAutoantibodies to amyloid-? and Alzheimer's disease
Hyman, B. T., Smith, C., Buldyrev, I., Whelan, C., Brown, H., Tang, M.-X., & Mayeux, R. (2001) · Annals of Neurology · doi:10.1002/ana.1061 · Cited by 143
β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration
Lodygin, D., Hermann, M., Schweingruber, N., Flügel-Koch, C., Watanabe, T., Schlosser, C., Merlini, A., Körner, H., Chang, H.-F., Fischer, H. J., et al. (2019) · Nature · doi:10.1038/s41586-019-0964-2 · Cited by 140
Obermeier, B., Lovato, L., Mentele, R., Brück, W., Forne, I., Imhof, A., Lottspeich, F., Turk, K. W., Willis, S. N., Wekerle, H., et al. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.01.010 · Cited by 139
NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody
Malviya, M., Barman, S., Golombeck, K. S., Planagumà, J., Mannara, F., Strutz‐Seebohm, N., Wrzos, C., Demir, F., Baksmeier, C., Steckel, J., et al. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.444 · Cited by 138
Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain
Saadoun, S., Waters, P., Owens, G. P., Bennett, J. L., Vincent, A., & Papadopoulos, M. C. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-35 · Cited by 137
Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies
Fujimori, J., Takai, Y., Nakashima, I., Sato, D. K., Takahashi, T., Kaneko, K., Nishiyama, S., Watanabe, M., Tanji, H., Kobayashi, M., et al. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-315094 · Cited by 135
B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro
Lisak, R. P., Nedelkoska, L., Benjamins, J. A., Schalk, D. L., Bealmear, B., Touil, H., Li, R., Muirhead, G., & Bar‐Or, A. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.05.004 · Cited by 135
Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
Schröder, J. B., Pawlowski, M., Meyer zu Hörste, G., Gross, C. C., Wiendl, H., Meuth, S. G., Ruck, T., & Warnecke, T. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.01081 · Cited by 134
Häusler, D., Häusser‐Kinzel, S., Feldmann, L., Torke, S., Lepennetier, G., Bernard, C. C. A., Zamvil, S. S., Brück, W., Lehmann‐Horn, K., & Weber, M. S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810470115 · Cited by 134
Self-citationJiang, Q., Jin, S., Jiang, Y., Liao, M., Feng, R., Zhang, L., Liu, G., & Hao, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-015-9670-8 · Cited by 132
Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production
Cotzomi, E., Stathopoulos, P., Lee, C. S., Ritchie, A. M., Soltys, J. N., Delmotte, F. R., Oe, T., Sng, J., Jiang, R., Ma, A. K., et al. (2019) · Brain · doi:10.1093/brain/awz106 · Cited by 132
B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas
Anthony, I., Crawford, D. H., & Bell, J. E. (2003) · Brain · doi:10.1093/brain/awg118 · Cited by 130
Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis
Chalmoukou, K., Alexopoulos, H., Akrivou, S., Stathopoulos, P., Reindl, M., & Dalakas, M. C. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000131 · Cited by 127
Hacohen, Y., Rossor, T. E., Mankad, K., Chong, W. K., Lux, A. L., Wassmer, E., Lim, M. J., Barkhof, F., Ciccarelli, O., & Hemingway, C. A. (2017) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.13649 · Cited by 127
Soltys, J., Liu, Y., Ritchie, A., Wemlinger, S., Schaller, K., Schumann, H., Owens, G. P., & Bennett, J. L. (2019) · Journal of Clinical Investigation · doi:10.1172/jci122942 · Cited by 124
Wilson, R., Makuch, M., Kienzler, A., Varley, J. A., Taylor, J., Woodhall, M. R., Palace, J. A., Leite, M. I., Waters, P. J., & Irani, S. R. (2018) · Brain · doi:10.1093/brain/awy010 · Cited by 123
Martínez‐Hernández, E., Sepúlveda, M., Rostasy, K. M., Höftberger, R., Graus, F., Harvey, R. J., Saiz, A., & Dalmau, J. O. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.3602 · Cited by 122
Haase, C. G., Guggenmos, J., Brehm, U., Andersson, M., Olsson, T. P., Reindl, M., Schneidewind, J. M., Zettl, U. K., Heidenreich, F., Berger, T., et al. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00462-8 · Cited by 121
Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression
Алексеевна, Г. М., Sewell, R. D. E., Yanamandra, K., Davidova, T. V., Kucheryanu, V. G., Bocharov, E. V., Bocharova, O. A., Polyschuk, V. V., Sherstnev, V. V., & Morozova‐Roche, L. A. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.12.001 · Cited by 121
Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease
Besong-Agbo, D., Wolf, E., Jessen, F., Oechsner, M., Hametner, E., Poewe, W., Reindl, M., Oertel, W. H., Noelker, C., Bacher, M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31827b90d1 · Cited by 120
Experimental Destruction of Substantia Nigra Initiated by Parkinson Disease Immunoglobulins
Chen, S., Le, W. D., Xie, W. J., Alexianu, M. E., Engelhardt, J. I., Siklós, L., & Appel, S. H. (1998) · Archives of Neurology · doi:10.1001/archneur.55.8.1075 · Cited by 118
Harp, C. T., Ireland, S. J., Davis, L. S., Remington, G. M., Cassidy, B., Cravens, P. D., Stüve, O., Lovett‐Racke, A. E., Eagar, T. N., Greenberg, B. M., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.201040516 · Cited by 117
Yahr, M. D., Goldensohn, S. S., & Kabat, E. A. (1954) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1954.tb54099.x · Cited by 115
Han, X., Stocking, G., Gebbie, M. A., & Appelbaum, R. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118183 · Cited by 110
Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss
Ratelade, J., Zhang, H., Saadoun, S., Bennett, J. L., Papadopoulos, M. C., & Verkman, A. S. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0986-4 · Cited by 108
Anti‐myelin basic protein and anti‐proteolipid protein specific forms of multiple sclerosis
Warren, K. G., Catz, I., Johnson, E., & Mielke, B. (1994) · Annals of Neurology · doi:10.1002/ana.410350307 · Cited by 105
Madireddy, L., Patsopoulos, N. A., Cotsapas, C. J., Bos, S. D., Beecham, A. H., McCauley, J. L., Kim, K., Jia, X., Santaniello, A., Caillier, S. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09773-y · Cited by 105
Parker Harp, C. R., Archambault, A. S., Sim, J., Ferris, S. T., Mikesell, R. J., Koni, P. A., Shimoda, M., Linington, C., Russell, J. H., & Wu, G. F. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402236 · Cited by 97
Meinl, E., Krumbholz, M., Derfuss, T. J., Junker, A., & Hohlfeld, R. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.06.032 · Cited by 96
Alterations in the Peripheral Immune System in Dementia
Busse, M., Michler, E., von Hoff, F., Dobrowolny, H., Hartig, R., Frodl, T., & Busse, S. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161304 · Cited by 94
Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients
Eggers, E. L., Michel, B. A., Wu, H., Wang, S.-Z., Bevan, C. J., Abounasr, A., Pierson, N. S., Bischof, A., Kazer, M., Leitner, E., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92724 · Cited by 93
Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
Lehmann‐Horn, K., Schleich, E., Hertzenberg, D., Hapfelmeier, A., Kümpfel, T., von Bubnoff, N. C. C., Hohlfeld, R., Berthele, A., Hemmer, B., & Weber, M. S. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-146 · Cited by 93
Uzawa, A., Mori, M., Sawai, S., Masuda, S., Muto, M., Uchida, T., Ito, S., Nomura, F., & Kuwabara, S. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.03.020 · Cited by 92
Blauth, K., Soltys, J., Matschulat, A., Reiter, C. R., Ritchie, A., Baird, N. L., Bennett, J. L., & Owens, G. P. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1500-6 · Cited by 92
Steele, N. Z. R., Carr, J. S., Bonham, L. W., Geier, E. G., Damotte, V., Miller, Z. A., Desikan, R. S., Boehme, K. L., Mukherjee, S., Crane, P. K., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002272 · Cited by 91
Sergott, R. C., Bennett, J. L., Rieckmann, P., Montalbán, X., Mikol, D. D., Freudensprung, U., Plitz, T., & van Beek, J. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.02.019 · Cited by 91
Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology
Pauli, F. D., Höftberger, R., Reindl, M., Beer, R., Rhomberg, P., Schanda, K., Sato, D. K., Fujihara, K., Lassmann, H., Schmutzhard, E., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000175 · Cited by 91
Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation
Beltrán, E., Obermeier, B., Moser, M., Coret, F., Simó, M., Boscá, I., Miralles, F. C. P., Villar, L. M., Şenel, M., Tumani, H., et al. (2014) · Brain · doi:10.1093/brain/awu205 · Cited by 90
Hillebrand, S., Schanda, K., Nigritinou, M., Tsymala, I., Böhm, D., Peschl, P., Takai, Y., Fujihara, K., Nakashima, I., Misu, T., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1950-8 · Cited by 90
In multiple sclerosis, oligoclonal bands connect to peripheral B‐cell responses
Bankoti, J., Apeltsin, L., Hauser, S. L., Allen, S., Albertolle, M. E., Witkowska, H. E., & von Büdingen, H. ‐. (2014) · Annals of Neurology · doi:10.1002/ana.24088 · Cited by 89
Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders
Petereit, H.-F., & Rubbert‐Roth, A. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508098268 · Cited by 87
Depletion of B Lymphocytes From Cerebral Perivascular Spaces by Rituximab
Martin, M. D. P., Cravens, P. D., Winger, R. C., Kieseier, B. C., Cepok, S., Eagar, T. N., Zamvil, S. S., Weber, M. S., Frohman, E. M., Kleinschmidt-DeMasters, B. K., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.157 · Cited by 87
Self-citationHerges, K., de Jong, B. A., Kolkowitz, I., Dunn, C., Mandelbaum, G., Ko, R. M., Maini, A., Han, M. H., Killestein, J., Polman, C., et al. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512440060 · Cited by 87
Human antibodies reactive with beta-amyloid protein in Alzheimer's disease.
Gaskin, F., Finley, J., Fang, Q., Xu, S., & Fu, S. M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.1181 · Cited by 84
Brickshawana, A., Hinson, S. R., Romero, M. F., Lucchinetti, C. F., Guo, Y., Buttmann, M., McKeon, A., Pittock, S. J., Chang, M.-H., Chen, A.-P., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70141-3 · Cited by 83
Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
Jesse, S., Brettschneider, J., Süssmuth, S. D., Landwehrmeyer, B. G., Arnim, C. A. F., Ludolph, A. C., Tumani, H., & Otto, M. (2011) · Journal of Neurology · doi:10.1007/s00415-010-5876-x · Cited by 81
Ritchie, A. M., Gilden, D. H., Williamson, R. A., Burgoon, M. P., Yu, X., Helm, K. M., Corboy, J. R., & Owens, G. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.649 · Cited by 78
Hollenbach, J. A., Norman, P. J., Creary, L. E., Damotte, V., Montero-Martin, G., Caillier, S., Anderson, K. M., Misra, M. K., Nemat-Gorgani, N., Osoegawa, K., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821778116 · Cited by 76
Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases
Kowarik, M. C., Grummel, V., Wemlinger, S. M., Buck, D., Weber, M. S., Berthele, A., & Hemmer, B. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7145-2 · Cited by 75
Clinical Trials of Intravenous Immunoglobulin for Alzheimer’s Disease
Relkin, N. R. (2014) · Journal of Clinical Immunology · doi:10.1007/s10875-014-0041-4 · Cited by 75
Antigen microarrays identify CNS-produced autoantibodies in RRMS
Quintana, F. J., Farez, M. F., Izquierdo, G., Lucas, M., Cohen, I. R., & Weiner, H. L. (2012) · Neurology · doi:10.1212/wnl.0b013e318247f9f3 · Cited by 75
VH4 Gene Segments Dominate the Intrathecal Humoral Immune Response in Multiple Sclerosis
Owens, G. P., Winges, K. M., Ritchie, A. M., Edwards, S. J., Burgoon, M. P., Lehnhoff, L., Nielsen, K., Corboy, J. R., Gilden, D. H., & Bennett, J. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.6343 · Cited by 74
Kowarik, M. C., Astling, D. P., Gasperi, C., Wemlinger, S. M., Schumann, H., Dzieciątkowska, M., Ritchie, A. M., Hemmer, B., Owens, G. P., & Bennett, J. L. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.418 · Cited by 74
The Gut Microbiome in Neuromyelitis Optica
Zamvil, S. S., Spencer, C. M., Baranzini, S. E., & Cree, B. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0594-z · Cited by 74
Self-citationBulati, M., Buffa, S., Martorana, A., Gervasi, F., Camarda, C., Azzarello, D. M., Monastero, R., Caruso, C., & Colonna-Romano, G. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-142412 · Cited by 72
Ratelade, J., Bennett, J. L., & Verkman, A. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.297275 · Cited by 70
Liu, Y., Given, K. S., Harlow, D. E., Matschulat, A. M., Macklin, W. B., Bennett, J. L., & Owens, G. P. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0428-6 · Cited by 69
Gα11 mutation in mice causes hypocalcemia rectifiable by calcilytic therapy
Gorvin, C. M., Hannan, F. M., Howles, S. A., Babinsky, V. N., Piret, S. E., Rogers, A., Freidin, A. J., Stewart, M., Paudyal, A., Hough, T. A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.91103 · Cited by 68
Sudduth, T. L., Greenstein, A., & Wilcock, D. M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1220-13.2013 · Cited by 67
B cell repertoire expansion occurs in meningeal ectopic lymphoid tissue
Lehmann-Horn, K., Wang, S.-Z., Sagan, S. A., Zamvil, S. S., & von Büdingen, H.-C. (2016) · JCI Insight · doi:10.1172/jci.insight.87234 · Cited by 67
Self-citationPauli, F. D., & Berger, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02753 · Cited by 67
B cells of multiple sclerosis patients induce autoreactive proinflammatory T cell responses
Fraussen, J., Claes, N., Wijmeersch, B. V., van Horssen, J., Stinissen, P., Hupperts, R., & Somers, V. A. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.10.001 · Cited by 65
Horvath, I., Iashchishyn, I. A., Forsgren, L., & Morozova-Roche, L. A. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00063 · Cited by 64
Gong, J., Qiu, W., Zeng, Q., Liu, X., Sun, X., Li, H., Yang, Y., Wu, A., Bao, J., Wang, Y., et al. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518790396 · Cited by 64
Harp, C. T., Lee, J., Lambracht‐Washington, D., Cameron, E. M., Olsen, G. M., Frohman, E. M., Racke, M. K., & Monson, N. L. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.10.020 · Cited by 63
HLA-DR Alleles in Amyloid β-Peptide Autoimmunity: A Highly Immunogenic Role for the DRB1*1501 Allele
Zota, V., Nemirovsky, A., Baron, R., Fisher, Y., Selkoe, D. J., Altmann, D. M., Weiner, H. L., & Monsonego, A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900620 · Cited by 62
The effects of intrathecal rituximab on biomarkers in multiple sclerosis
Topping, J. H., Dobson, R., Lapin, S. V., Maslyanskiy, А. L., Kropshofer, H., Leppert, D., Giovannoni, G., & Evdoshenko, E. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2016.01.001 · Cited by 61
Söllvander, S., Ekholm-Pettersson, F., Brundin, R.-M., Westman, G., Kilander, L., Paulie, S., Lannfelt, L., & Sehlin, D. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-150236 · Cited by 60
Akhtar, R. S., Licata, J. P., Luk, K. C., Shaw, L. M., Trojanowski, J. Q., & Lee, V. M. ‐. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14330 · Cited by 60
Antibody responses to EBV and native MOG in pediatric inflammatory demyelinating CNS diseases
Selter, R., Brilot, F., Grummel, V., Kraus, V., Cepok, S., Dale, R. C., & Hemmer, B. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e04096 · Cited by 58
Nerrant, E., Salsac, C., Charif, M., Ayrignac, X., Dalliere, C. C., Castelnovo, G., Goulabchand, R., Tisseyre, J., Raoul, C., Eliaou, J., et al. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514531086 · Cited by 58
Shalash, A., Salama, M., Makar, M., Roushdy, T., Elrassas, H. H., Mohamed, W., El-Balkimy, M., & Abou Donia, M. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00720 · Cited by 58
Antimyelin Antibodies with No Progression to Multiple Sclerosis
Pelayo, R., Tintoré, M., Montalbán, X., Rovira, À., Espejo, C., Reindl, M., & Berger, T. (2007) · New England Journal of Medicine · doi:10.1056/nejmc062467 · Cited by 57
Antibodies in multiple sclerosis oligoclonal bands target debris
Winger, R. C., & Zamvil, S. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609246113 · Cited by 57
Self-citationMaftei, M., Thurm, F., Schnack, C., Tumani, H., Otto, M., Elbert, T., Kolassa, I.-T., Przybylski, M., Manea, M., & von Arnim, C. A. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068996 · Cited by 55
Circulating CCR7+ICOS+ Memory T Follicular Helper Cells in Patients with Multiple Sclerosis
Fan, X., Jin, T., Zhao, S., Liu, C., Han, J., Jiang, X., & Jiang, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134523 · Cited by 53
Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease
Kraus, V., Srivastava, R., Kalluri, S. R., Seidel, U., Schuelke, M., Schimmel, M., Rostasy, K. M., Leiz, S., Hosie, S., Grummel, V., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000097 · Cited by 53
Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis
Greenfield, A. L., Dandekar, R., Ramesh, A., Eggers, E. L., Wu, H., Laurent, S. A., Harkin, W. E., Pierson, N. S., Weber, M. S., Henry, R. G., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126599 · Cited by 52
Proinflammatory B-cell profile in the early phases of MS predicts an active disease
Guerrier, T., Labalette, M., Launay, D., Lee-Chang, C., Outteryck, O., Lefèvre, G., Vermersch, P., Dubucquoi, S., & Zéphir, H. (2017) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000431 · Cited by 50
Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions
Schirmer, L., Srivastava, R., Kalluri, S. R., Böttinger, S., Herwerth, M., Carassiti, D., Srivastava, B., Gempt, J., Schlegel, J., Kuhlmann, T., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24168 · Cited by 45
Integrity of the blood–cerebrospinal fluid barrier in early Parkinson's disease
Häussermann, P., Kuhn, W., Przuntek, H., & Müller, T. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01574-9 · Cited by 45
Immunological memory to hyperphosphorylated tau in asymptomatic individuals
Pascual, G., Wadia, J. S., Zhu, X., Keogh, E., Kükrer, B., van Ameijde, J., Inganäs, H., Siregar, B., Perdok, G., Diefenbach, O., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1705-y · Cited by 45
Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally
Svenningsson, A., Bergman, J., Dring, A. M., Vågberg, M., Birgander, R., Lindqvist, T., Gilthorpe, J. D., & Bergenheim, T. A. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000079 · Cited by 44
Álvarez, E., Piccio, L. M., Mikesell, R. J., Trinkaus, K. M., Parks, B. J., Naismith, R. T., & Cross, A. H. (2015) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217315623800 · Cited by 44
Maintenance of B lymphocyte‐related clones in the cerebrospinal fluid of multiple sclerosis patients
Colombo, M., Dono, M., Gazzola, P., Chiorazzi, N., Mancardi, G., & Ferrarini, M. (2003) · European Journal of Immunology · doi:10.1002/eji.200324144 · Cited by 42
Rivas, J. R., Ireland, S. J., Chkheidze, R., Rounds, W. H., Lim, J. S., Johnson, J. T., Ramirez, D. M. O., Ligocki, A. J., Chen, D., Guzman, A. A., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1627-0 · Cited by 42
Yao, X., & Verkman, A. S. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0462-4 · Cited by 41
MRI phenotypes with high neurodegeneration are associated with peripheral blood B-cell changes
Comabella, M., Cantó, E., Nurtdinov, R., Río, J., Villar, L. M., Picón, C., Castilló, J., Fissolo, N., Aymerich, F. X., Auger, C., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv473 · Cited by 40
Treatment of Neuromyelitis Optica With Rituximab: Retrospective Analysis of 25 Patients
Leavitt, J. A. (2009) · Yearbook of Neurology and Neurosurgery · doi:10.1016/s0513-5117(09)79219-1 · Cited by 40
Thaler, F., Thaller, A., Biljecki, M., Schuh, E., Winklmeier, S., Mahler, C. F., Gerhards, R., Völk, S., Schnorfeil, F., Subklewe, M. S., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25414 · Cited by 34
Intrathecal anti‐ CD 20 efficiently depletes meningeal B cells in CNS autoimmunity
Lehmann‐Horn, K., Häusser‐Kinzel, S., Feldmann, L., Radelfahr, F., Hemmer, B., Traffehn, S., Bernard, C. C. A., Stadelmann, C., Brück, W., & Weber, M. S. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.71 · Cited by 28
Kobo, H., Bar‐Shira, A., Dahary, D., Gan‐Or, Z., Mirelman, A., Goldstein, O., Giladi, N., & Orr‐Urtreger, A. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.09.005 · Cited by 26
Onset of secondary progressive MS after long‐term rituximab therapy – a case report
von Büdingen, H. ‐., Bischof, A., Eggers, E. L., Wang, S., Bevan, C. J., Cree, B., Henry, R. G., & Hauser, S. L. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.377 · Cited by 25
Multiple Sclerosis and Antibodies against KIR4.1
Pröbstel, A., Kühle, J., Lecourt, A.-C., Vock, I., Sanderson, N., Kappos, L., & Derfuss, T. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1507131 · Cited by 24
Self-citationEvaluation of KIR4.1 as an Immune Target in Multiple Sclerosis
Chastre, A., Hafler, D. A., & O’Connor, K. C. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1513302 · Cited by 24
Harp, C. R. P., Archambault, A. S., Sim, J. E., Shlomchik, M. J., Russell, J. H., & Wu, G. F. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199694 · Cited by 24
Kubo, M., Nagashima, R., Ohta, E., Maekawa, T., Isobe, Y., Kurihara, M., Eshima, K., Iwabuchi, K., Sasaoka, T., Azuma, S., et al. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.01.005 · Cited by 20
Cree, B., Bennett, J. L., Kim, H. J., Weinshenker, B., Pittock, S. J., Wingerchuk, D. M., Fujihara, K., Paul, F., Cutter, G., Marignier, R., et al. (2019) · Neurology · doi:10.1212/wnl.92.15_supplement.plen02.001 · Cited by 8
Jarius, S., Wuthenow, A.-B., & Wildemann, B. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.09.005 · Cited by 7
An overview of the necessary thymic contributions to tolerance in transplantation
Scalea, J. R., Hickman, J. B., Moore, D. J., & Brayman, K. L. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.10.010 · Cited by 4
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cited by
Treatment of Multiple Sclerosis: A Review
Hauser, S. L., & Cree, B. A. C. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.05.049 · Cited by 969
B cell depletion therapies in autoimmune disease: advances and mechanistic insights
Lee, D. S. W., Rojas, O. L., & Gommerman, J. L. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00092-2 · Cited by 658
CD39/CD73/A2AR pathway and cancer immunotherapy
Xia, C., Yin, S., To, K. K. W., & Fu, L. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01733-x · Cited by 399
CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease
Williams, G. P., Schonhoff, A. M., Jurkuvenaite, A., Gallups, N. J., Standaert, D. G., & Harms, A. S. (2021) · Brain · doi:10.1093/brain/awab103 · Cited by 306
Periphery and brain, innate and adaptive immunity in Parkinson’s disease
Harms, A. S., Ferreira, S. A., & Romero-Ramos, M. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02268-5 · Cited by 272
Metadata
- Authors
- Sabatino, J. J., Pröbstel, A.-K., & Zamvil, S. S.
- Venue
- Nature Reviews Neuroscience
- Published
- 2019-11-11
- Volume
- 20
- Issue
- 12
- Pages
- 728-745
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2985088294
- Cited by
- 343
- References
- 334
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.